E Purines announced it raised $65,000 in an amended filing from an offering of $5 Million

Company

Location

About

ePurines, LLC is a drug development company focused on innovative purinergic-based therapies for obesity, metabolic syndrome renal and liver diseases. The core technologies of the ePurines were developed in the VA labs and are patented by the US Department of Veterans Affairs. The first value proposition of ePurines is: “To Promote the Health of Those Who Served Our Country”.